Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07278336 |
| Title | A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | AbbVie |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ISR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| NEXT Oncology - San Antonio /ID# 278606 | RECRUITING | San Antonio | Texas | 78229 | United States | Details |
| Start Mountain Region /ID# 278609 | RECRUITING | West Valley City | Utah | 84119 | United States | Details |
| Next Virginia /ID# 278607 | RECRUITING | Fairfax | Virginia | 22031 | United States | Details |
| Rambam Health Care Campus /ID# 278418 | RECRUITING | Haifa | 3109601 | Israel | Details | |
| Hadassah Medical Center-Hebrew University /ID# 278420 | RECRUITING | Jerusalem | 91120 | Israel | Details |